Homeopathic treatment of vaginal symptoms after menopause

An open observational trial of individualized homoeopathic treatment of vulvovaginal symptoms in post-menopausal women and validation of the translated Vulvo-vaginal Symptom Questionnaire in Bengali language

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/04/013272

Enrollment

100

Registered

2018-04-13

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Postmenopausal vulvo-vaginitis

Interventions

Intervention1: Indicated homoeopathic medicines in centesimal or fifty millesimal potencies: Indicated homoeopathic medicines in centesimal or fifty millesimal potencies, as decided appropriate to the

dosage and repetition depending upon the individual requirement of the cases. In 50 millesimal scale, a single medicated cane sugar globules of poppy seed size (no. 10) shall be dissolved in 90 ml dis

16 doses to be marked on the vial

each dose of 5 ml to be taken after 10 uniformly forceful downward strokes to the vial in 45 ml normal water in a clean cup, to stir well, to take 5 ml of this liquid orally, and to discard rest of th

Eligibility

Inclusion criteria

Inclusion criteria: 1. Postmenopausal women suffering from vulvo-vaginal symptoms for at least last 3 months 2. Age: 50-60 years 3. Ability to read Bengali 5. Patients giving written consent to participate 6. Any standard or other CAM therapy, if ongoing, discontinued for at least 1 month

Exclusion criteria

Exclusion criteria: 1. Patients with known vulvar dermatoses including: Lichen Sclerosus, Lichen Planus, Psoriasis, Behcetâ??s disease, Hidradenitis Suppurativa, Anorectal Crohnâ??s disease, or Genital Herpes 2. Patients who had an artificial menopause and were on HRT 3. Patients having history of breast or reproductive organ cancer 4. Major gynecological surgery in last 6 months 5. Patients with psychiatric diseases. 6. Cases suffering from uncontrolled systemic illness or life-threatening infections 7. Cases already undergoing homoeopathic treatment for any chronic disease 8. Substance abuse and/or dependence 9. Self-reported immune-compromised state

Design outcomes

Primary

Measure	Time frame
Translated Bengali version of vulvo-vaginal symptom questionnaire (VSQ)Timepoint: Baseline and after 3 months	—

Secondary

Measure	Time frame
Translated Bengali version of Utial Quality of Life (UQOL) questionnaireTimepoint: Baseline and after 3 months	—

Countries

India

Contacts

Public ContactSubhranil Saha

National Institute of Homoeopathy, Ministry of AYUSH, Govt. of India

drsubhranilsaha@hotmail.com9831063837

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026